A Phase II Study of the Effect of ACE Inhibitors on Pro-Angiogenic Hormones in Cancer Patients With Hypertension.
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2017
At a glance
- Drugs Losartan (Primary) ; Ramipril (Primary) ; Benazepril; Lisinopril
- Indications Hypertension
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 31 Jan 2013 Planned End Date changed from 1 Feb 2014 to 1 Feb 2016 as reported by ClinicalTrials.gov.
- 17 Apr 2012 Planned End Date changed from 1 Feb 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.